CIK 0001641489 · Non-accelerated filer<br>Smaller reporting company
vTv Therapeutics Inc.
Sign in to watch- Ticker
- VTVT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473916571
- Phone
- 336-841-0300
- Business address
- 3980 PREMIER DR, SUITE 310, HIGH POINT, NC, 27265
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 15,000 shares at an average $5.82 ($87,279)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Unregistered share sale
- 4 Open-market buy 10% owner bought 10,000 shares at $5.83 ($58,250)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 10,000 shares at $6.43 ($64,257)
- 4 Open-market buy 10% owner bought 20,000 shares at $6.05 ($121,030)
- 4 Open-market buy 10% owner bought 10,000 shares at $6.58 ($65,791)
- 4 Open-market buy 10% owner bought 15,000 shares at an average $6.41 ($96,187)
- 4 Open-market buy 10% owner bought 15,000 shares at $6.40 ($96,057)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,710 shares at $6.20 ($35,385)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 290 shares at $6.20 ($1,798)
- 8-K Event Regulation FD disclosure
Page 27 of 31 · 602 filings